PDA Syringe Conference 2009: Gerresheimer Focuses On Injection Practice

On October 27–28, 2009, Venice provides the backdrop for the science congress at which pharmacists and medical practitioners from all over Europe are expected. As one of the leading worldwide specialists in injection systems the Gerresheimer Group is taking an active part again this time with a specialist lecture and a small exhibition.
 
In the highly specialized field of injections, Gerresheimer - with a product portfolio which ranges from ready-to-fill sterile syringes and pen systems to cartridges, injection vials and ampoules – enjoys a reputation as one of the most versatile partners for the pharmaceutics industry. "The segment presents new and different challenges all the time", says Burkhard Lingenberg, Director of Marketing and Communication for the Gerresheimer Group: so continuous intensive exchange of knowledge and experience between all the disciplines involved and from all relevant viewpoints is all the more important, he stresses. The Group has accompanied the successful PDA congress series since the start; in fact it was one of its initiators. 
 
Its lecture this year elucidates the suitability of pre-filled syringe systems for practical use. Dr. Arno Fries compares the current technologies with the numerous requirements: those of customers in the pharma industry and at the same time those of specialist medical staff, as well as patients as end users. Here the USA Marketing Director and Head of Product Management for syringes with Gerresheimer Bünde takes up a subject area of great interest in many regards, where a role is played by widely varying product safety factors as well as convenience considerations, which also make a decisive contribution to correct and safe application in this area. The lecture is entitled: 'Suitability for use and safety of pre-filled syringes from the perspective of end users'.
 
A tabletop presentation on the fringe of the congress convincingly documents the high level of system development covering these requirements and many others right across the field of injections. For example, the latest generation of ready-to-fill (RTF®) all-glass syringes have an individual laser code on the finger flange, multicolor printing on the glass and Baked-On-RTF™ - the interior siliconisation process tailored especially for biopharmaceutics. These are complemented by intelligent closure solutions and application aids. With Clearject® syringe systems made of COP (Cyclic Olefin Polymer), a crystal-clear plastic, Gerresheimer furthermore offers special benefits for the demanding field of cytostatics and biopharmaceutics.